Portal de Periódicos da CAPES

Distribution of tumor-infiltrating immune cells in glioblastoma

2018; Future Medicine; Volume: 7; Issue: 4 Linguagem: Inglês

10.2217/cns-2017-0037

2045-0915

Enrique Orrego, Carlos A. Castañeda, Miluska Castillo, Luis A. Bernabe, Sandro Casavilca‐Zambrano, Arnab Chakravarti, Wei Meng, Pamela García-Corrochano, Maria R Villa-Robles, Rocio Zevallos, Ómar Mejìa, Pedro Deza, Carolina Belmar-López, Luis Pacheco Ojeda,

Cancer Immunotherapy and Biomarkers

Evaluation of features related to infiltrating immune cell level in glioblastoma.Tumor-infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis.CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4+ was associated with unmethylated MGMT (p = 0.016). Higher CD8+ was associated with larger tumoral size (p = 0.027). Higher CD163+ was associated with higher age (p = 0.044) and recursive partitioning analysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4+ (p < 0.05) were associated with longer overall survival.Macrophages are more frequent than TILs. Some subsets are associated with clinical features.